22nd Century Group Inc

XXII

$0.12

Closing

▼-8.75%

1D

▼-35.55%

YTD

Market cap

$5.25M

52 week high

$12.00

52 week low

$0.11

Volume

453,860

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Market cap

$5.25M

Analysts' Rating

BUY

Price Target (Mean)

41.11

Total Analysts

4

P/E

Operating Margin

-401.34%

Beta

1.54

Revenue Growth (Annual)

137.79%

52 week high

$12.00

52 week low

$0.11

Div. Yield

%

EPS Annual Growth

162.86

Note on Purification and Zakat

  • Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly). 
  • If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
  • For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them. 

Company Profile

22nd Century Group, Inc. is an agricultural biotechnology and intellectual property company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the consumer goods and pharmaceutical industries. The Company operates through two segments: Tobacco and Hemp/cannabis. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers’ branded filtered cigars and cigarettes. Its tobacco segment is engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. Its Hemp/cannabis segment is engaged in developing cannabidiol (CBD) wholesale extracts and bulk ingredient distillate or isolate.